<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33420941</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2240-2993</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Acta neurologica Belgica</Title><ISOAbbreviation>Acta Neurol Belg</ISOAbbreviation></Journal><ArticleTitle>A combined clinical and computational approach to understand the SOD1<sup>A4T</sup>-mediated pathogenesis of rapidly progressive familial amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>955</StartPage><EndPage>960</EndPage><MedlinePgn>955-960</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13760-020-01588-9</ELocationID><Abstract><AbstractText>Here, we aim to provide a comprehensive clinical and biomolecular description of familial amyotrophic lateral sclerosis (fALS) in a 25-year-old female patient with respect to the SOD1<sup>A4T</sup> genotype. The clinical diagnosis of the disease was based on family history, neurological examination, electroneurophysiological studies, and revised El Escorial criteria. The heterozygous presence of the A4T mutation in the proband was confirmed by PCR coupled with Sanger sequencing of exon 1 of the SOD1 gene. The mutation was introduced in silico into the three-dimensional structure of the native protein. After energy minimization and quality assessment, non-covalent interactions around threonine-4 and changes in protein stability were calculated computationally. The patient differed widely in age at onset, initial neurological symptoms and findings, and survival time from her kindred, in which several members are affected. SOD1<sup>A4T</sup>-linked fALS in this case had bulbar involvement at onset, a combination of lower and upper motor neuron signs and showed rapid progression. Unlike alanine-4, threonine-4 failed to engage in hydrophobic interactions with the vicinal non-polar amino acids. The overall fold of the modeled SOD1<sup>A4T</sup> mutant remained intact, but unfolding free energy estimations disclosed a decrease in the protein's stability. We report a phenotypically distinct patient with fALS due to the SOD1<sup>A4T</sup> mutation and further expand the largest pedigree ever published for SOD1<sup>A4T</sup>-linked fALS. Genotype&#x2012;phenotype correlation in fALS is complex, and it demands detailed clinical investigation and advanced scientific research. Awareness of the broadened phenotypic spectrum might potentially enhance the diagnosis and genetic counseling of fALS.</AbstractText><CopyrightInformation>&#xa9; 2021. Belgian Neurological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Diker</LastName><ForeName>Sevda</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8944-0672</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, Near East University, Nicosia, Cyprus. sevdaomrumdiker@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gelener</LastName><ForeName>P&#x131;nar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, University of Kyrenia, Kyrenia, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teral&#x131;</LastName><ForeName>Kerem</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry, Faculty of Medicine, Near East University, Nicosia, Cyprus.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DESAM Institute, Near East University, Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ergoren</LastName><ForeName>Mahmut Cerkez</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>DESAM Institute, Near East University, Nicosia, Cyprus.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Genetics, Faculty of Medicine, Near East University, Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tunca</LastName><ForeName>Ceren</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Medicine, Neurodegeneration Research Laboratory (NDAL), Ko&#xe7; University, KUTTAM, Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ba&#x15f;ak</LastName><ForeName>A Nazl&#x131;</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>School of Medicine, Neurodegeneration Research Laboratory (NDAL), Ko&#xe7; University, KUTTAM, Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Ersin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Acta Neurol Belg</MedlineTA><NlmUniqueID>0247035</NlmUniqueID><ISSNLinking>0300-9009</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>2ZD004190S</RegistryNumber><NameOfSubstance UI="D013912">Threonine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013912" MajorTopicYN="N">Threonine</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">A4T mutation</Keyword><Keyword MajorTopicYN="N">Cu&#x2013;Zn superoxide dismutase</Keyword><Keyword MajorTopicYN="N">Familial amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">fALS</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>9</Day><Hour>12</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33420941</ArticleId><ArticleId IdType="doi">10.1007/s13760-020-01588-9</ArticleId><ArticleId IdType="pii">10.1007/s13760-020-01588-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alsultan AA, Waller R, Heath PR et al (2016) The genetics of amyotrophic lateral sclerosis: current insights. Degener Neurol Neuromuscul Dis 6:49&#x2013;64</Citation><ArticleIdList><ArticleId IdType="pubmed">30050368</ArticleId><ArticleId IdType="pmc">6053097</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhit R, Chakrabartty A (2006) Structure, folding, and misfolding of Cu, Zn superoxide dismutase in amyotrophic lateral sclerosis. Biochimica et Biophysica Acta (BBA) 1762:1025&#x2013;1037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.05.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Kirby J, Grierson AJ et al (2011) Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol 7:616&#x2013;630</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A et al (2017) Amyotrophic lateral sclerosis (2017) [published correction appears in Nat Rev Dis Primers. 20;3:17085]. Nat Rev Dis Primers 3:17071</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur SJ, McKeown SR, Rashid S (2016) Mutant SOD1 mediated pathogenesis of amyotrophic lateral sclerosis. Gene 577:109&#x2013;118</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.11.049</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O, Bordoni M, Diamanti L, Sproviero D, Gagliardi S, Cereda C (2018) SOD1 in amyotrophic lateral sclerosis: &#x201c;ambivalent&#x201d; behavior connected to the disease. Int J Mol Sci 19(5):1345</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051345</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangwan S, Eisenberg DS (2016) Perspective on SOD1 mediated toxicity in Amyotrophic Lateral Sclerosis. Post&#x119;py Biochemii 62(3):362&#x2013;369</Citation><ArticleIdList><ArticleId IdType="doi">10.18388/pb.2016_37</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi Y, Homma K, Ichijo H (2016) SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS. Adv Biol Regul 60:95&#x2013;104</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbior.2015.10.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotunno MS, Bosco DA (2013) An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. Front Cell Neurosci 7:253</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00253</ArticleId></ArticleIdList></Reference><Reference><Citation>Juneja T, Pericak-Vance MA, Laing NG, Dave S, Siddique T (1997) Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu, Zn superoxide dismutase. Neurology 48:55&#x2013;57</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.48.1.55</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano R, Sato S, Inuzuka T et al (1994) A novel mutation in Cu/Zn superoxide dismutase gene in Japanese familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun 200:695</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1994.1506</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanishi T, Kishikawa M, Miyazaki A et al (1998) Simple and defined method to detect the SOD-1 mutants from patients with familial amyotrophic lateral sclerosis by mass spectrometry. J Neurosci Methods 81:41&#x2013;44</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-0270(98)00012-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksoy H, Dean G, Elian M et al (2003) A4T mutation in the SOD1 gene causing familial amyotrophic lateral sclerosis. Neuroepidemiology 22(4):235&#x2013;238</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000070564</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato T, Nakanishi T, Yamamoto Y et al (2005) Rapid disease progression correlates with instability of mutant SOD1 in familial ALS. Neurology 65:1954&#x2013;1957</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000188760.53922.05</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek W, Koh SH, Park JS et al (2011) A novel codon4 mutation (A4F) in the SOD1 gene in familial amyotrophic lateral sclerosis. J Neurol Sci 306:157&#x2013;159</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2011.03.041</ArticleId></ArticleIdList></Reference><Reference><Citation>Naruse H, Iwata A, Takahashi Y et al (2013) Familial amyotrophic lateral sclerosis with novel A4D SOD1 mutation with late age at onset and rapid progressive course. Neurol Clin Neurosci 1:45&#x2013;47</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ncn3.8</ArticleId></ArticleIdList></Reference><Reference><Citation>Hand CK, Rouleau GA (2002) Familial amyotrophic lateral sclerosis. Muscle Nerve 25(2):135&#x2013;159</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10001</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Zhao H, Lu M et al (2005) A rare Cu/Zn superoxide dismutase mutation causing familial amyotrophic lateral sclerosis with variable age of onset and incomplete penetrance in China. Amyotroph Lateral Scle 6(4):234&#x2013;238</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820510044478</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293e299</Citation></Reference><Reference><Citation>Strange RW, Antonyuk S, Hough MA et al (2003) The structure of holo and metal-deficient wild-type human Cu, Zn superoxide dismutase and its relevance to familial amyotrophic lateral sclerosis. J Mol Biol 328:877&#x2013;891</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-2836(03)00355-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Hough MA, Grossmann JG, Antonyuk SV et al (2004) Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants. Proc Natl Acad Sci USA 101:5976&#x2013;5981</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0305143101</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman HM, Westbrook J, Feng Z et al (2000) The protein data bank. Nucleic Acids Res 28:235&#x2013;242</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/28.1.235</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieger E, Joo K, Lee J et al (2009) Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8. Proteins 77:114&#x2013;122</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.22570</ArticleId></ArticleIdList></Reference><Reference><Citation>Porollo A, Meller J (2007) Prediction-based fingerprints of protein&#x2013;protein interactions. Proteins 66:630&#x2013;645</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.21248</ArticleId></ArticleIdList></Reference><Reference><Citation>Tina KG, Bhadra R, Srinivasan N (2007) PIC: protein interactions calculator. Nucleic Acids Res 35:W473&#x2013;W476</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkm423</ArticleId></ArticleIdList></Reference><Reference><Citation>Laimer J, Hofer H, Fritz M, Wegenkittl S, Lackner P (2015) MAESTRO&#x2013;multi agent stability prediction upon point mutations. BMC Bioinf 16:116</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-015-0548-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Kuwabara S (2012) The split hand syndrome in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 83(4):399&#x2013;403</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-301456</ArticleId></ArticleIdList></Reference><Reference><Citation>Radunovic A, Annane D, Rafiq MK, Brassington R, Mustfa N (2017) Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 6 10:CD004427</Citation></Reference><Reference><Citation>Zou ZY, Zhou ZR, Che CH et al (2017) Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 88(7):540</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz ME, McKenna-Yasek D, Sapp PE et al (1997) Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis. Ann Neurol 41(2):210&#x2013;221</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410410212</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>